20 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28112925	44	Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.	University of Tennessee Health Science Center
27774128	38	Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead.	Ono Pharmaceutical
25100502	15	Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.	The University of Tennessee Health Science Center
23395664	66	Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.	The University of Utah
22894757	69	Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.	F. Hoffmann-La Roche
18178086	26	Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents.	Amgen
20056548	4	Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.	University of Tennessee Health Science Center
19800804	19	Structure-based drug design identifies novel LPA3 antagonists.	The University of Memphis
18467108	26	Identification of non-lipid LPA3 antagonists by virtual screening.	The University of Memphis
16913720	15	Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.	The University of Utah
16263282	43	Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.	University of Tennessee Health Science Center
16033271	81	Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.	University of Tennessee Health Science Center
15857137	10	Structure-activity relationships of fluorinated lysophosphatidic acid analogues.	The University of Utah
15225728	55	A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist.	University of Virginia
15177455	27	Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.	Oxford University
15125924	63	Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.	University of Virginia
32584034	38	Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry.	X-Chem
22180836	5	Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist.	University of Virginia